Researchers examined alcohol-induced psychomotor performance impairments among young adult alcohol consumers with alcohol usage disorders (AUDs).
BioMarin touts Voxzogo sales bump in Q2 results, notes ‘temporarily tight supply’
BioMarin is touting “record revenues” from the first half of 2023, spearheaded by the jump in sales of its achondroplasia drug Voxzogo — so much